bioMérieux社との共催によるGlobal-PPS年次総会を開催いたします。会議は2026年4月17日（金）09:30-13:00（中央ヨーロッパ標準時）、ドイツのミュンヘンで開催されるESCMID Global 2026の初日に行われます。.

私たちの体験談は、現場で働いている専門家が、Global-PPSツールの実体験を語っています。この記事では、医師であり、医療システムの研究者であり、インドネシアにおけるdrive-AMSプロジェクトの主要な貢献者であるララリシア・リマト博士にお話を伺います。彼女は、同国における抗菌薬耐性（AMR）の課題について考察し、Global-PPSが研究ツールから、抗菌薬使用と医療関連感染に関するインドネシアの国家サーベイランスシステムの礎石へと発展した経緯について説明しています。.

抗菌薬スチュワードシップの議論はしばしば病院に焦点が当てられるが、抗生物質の大部分は入院患者以外で処方されている。Global-PPS 外来患者モジュールは、この重大な知識のギャップを埋めるために作成されました。外来患者サーベイを実施するチームを支援するため、G-PPS チームは豊富なリソースを開発し、明確なガイダンス、トレーニング、実用的なツールを提供しています。.

Today, the Commonwealth Pharmacists Association (CPA) launches a new PPS Short Report & Intervention Guide. It functions as a practical resource designed to help healthcare facilities interpret their Point Prevalence Survey (PPS) results and identify targeted antimicrobial stewardship (AMS) interventions.

To mark the start of World Antimicrobial Awareness Week, we’re excited to share our new animated explainer video. This short piece introduces the basic features of the Global-PPS and shows how it served as a key piece of the puzzle within the behaviour-change approach of the now concluded drive-AMS project.

このインタビューでは、英連邦薬剤師協会（CPA）のプログラム責任者であるマクセンシア・ナビリョ氏に、アフリカ全土で抗菌薬耐性（AMR）に取り組んでいる彼女の仕事について聞いた。彼女は、AMRがなぜ医療システムに重大な脅威をもたらすのか、Global-PPSのようなデータ主導のイニシアチブの役割、CwPAMSやSPARCのようなプログラムがどのように抗菌薬スチュワードシップを強化するために地域チームをエンパワーしているかについての洞察を共有している。.

9月15日、Global-PPSの研究者であるイネス・パウエルスは、Global-PPSイニシアチブとdrive-AMSプロジェクトとの強力な結びつきを証明する博士論文を提出した。.

The Infection Control Africa Network (ICAN) regularly organizes IPC focused congresses. The 2025 ICAN Congress placed a strong emphasis on antimicrobial and diagnostic stewardship and for that reason, Global-PPS, in collaboration with bioMérieux, made a significant impact at the 9th International ICAN Congress in Cape Town, South Africa (29 June to 2 July 2025). Global-PPS convened experts, showcased research, and delivered practical insights into data-driven approaches for tackling antimicrobial resistance across the African continent.

ウィーンで開催されたESCMID世界会議2025において、Global-PPSはCritical Conversationsでスポットライトを浴びました：ポッドキャスト「AMR専門家の声」シリーズでスポットライトを浴びた。この18分間のエピソードでは、Global-PPSのリーダーであるErika Vlieghe教授とAnn Versportenがホストに加わり、Global Point Prevalence Surveyとその世界的な抗菌薬使用サーベイランスへの影響について専門知識を披露しました。.

Global Point Prevalence Surveyは、ヒトの病院や外来での抗菌薬使用を評価するために設計されている。しかし、最近の研究では、このツールが馬の病院でも使用できることが示された。これは、獣医療における抗菌薬耐性の増大という問題を研究する上で大きな価値がある。.

この度、JAC-Antimicrobial Resistance誌に、Global-PPS外来モジュールの開発と最初の評価に関する査読付き論文が掲載されました。.

先週、ウィーンで開催されたESCMID Global 2025大会の冒頭、bioMérieuxと共同で開催された年次総会に、グローバルポイント有病率調査コミュニティが集結した。160人以上の参加者が会場とオンラインの両方に参加し、抗菌薬スチュワードシップにおけるグローバルなコラボレーションの力を示す、活気に満ちた刺激的なイベントとなった。.

Global-PPSチームは、Global Point Prevalence Survey（Global-PPS）ネットワーク内の低・中所得国（LMICs）の病院において、抗菌薬スチュワードシップ（AMS）がどのように実施されているかを調査した最新の学術論文を発表した。.

Global-PPS has launched the innovative Outpatient Module to bridge the gap in antimicrobial surveillance for non-admitted patients. Designed for outpatient clinics, primary care centers, and emergency departments, this module provides detailed insights into prescribing patterns, patient characteristics, and antimicrobial use trends.

The Global-PPS team is excited to announce the release of new resources for the outpatient module, including tutorial videos and real-time feedback reports. The tutorial videos explain how to use the Global-PPS tool and enter your data. The real-time feedback report includes detailed personalized information on prescribing practices and quality indicators for the outpatient module of the Global-PPS.

Today marks the start of the World Antibiotic Awareness Week (WAAW), an annual initiative led by WHO bringing attention to AMR and promoting best practices worldwide. This year’s campaign emphasises the importance of education and taking concrete actions to tackle this critical healthcare challenge.

Meet Shaheen Mehtar, professor of Infection Prevention and Control in South Africa. As a founding member of the Infection Control Africa Network, she has played a pivotal role in shaping infection control practices across the continent. In this interview, Prof. Mehtar discusses her work with the Global Point Prevalence Survey, the successes and challenges of implementing antimicrobial stewardship programs, and her hopes for improving IPC efforts in both hospital and outpatient settings.

先駆的な病院疫学者であるビリャナ・カレビッチ博士は、感染制御と抗生物質スチュワードシップにそのキャリアを捧げてきた。このインタビューでは、ビリャナ氏が自身の仕事、セルビアとノルウェーにおける抗菌薬耐性（AMR）の課題、そして世界ポイント有病率調査（Global Point Prevalence Survey）への継続的な取り組みについて語る。.

Last Friday, the annual Global-PPS meeting in collaboration with bioMérieux took place on the occasion of ESCMID Global 2024, formerly known as ECCMID. Over 100 participants attended the hybrid meeting to learn more about the project’s activities, strategies and results. It was a special edition as Global-PPS also celebrated its 10 year anniversary!

A recent study compared antimicrobial prescribing patterns in paediatric patients from three hospitals in Sanandaj, Western Iran, with paediatric patients from hospitals in Southeast Asia and Europe. Standardised 2019 Global-PPS data were used.

Read our interview with Amanda Daniel, Lead Nurse and IPC Specialist from Wales who worked in a Ugandan hospital to help identify antimicrobial prescribing rates. The implementation of the Global-PPS in Uganda highlighted both the challenges and opportunities in addressing AMR and improving infection prevention and control practices.

We interviewed Dr. Herberth Maldonado from Guatemala, who has made great efforts in combatting antimicrobial resistance in his country. He shares his insights and experiences with Global-PPS, what challenges he faces and his hopes for the future.

Lagos University Teaching Hospital (LUTH), a tertiary care hospital in Nigeria, is a loyal member in the Global-PPS network with annual multiple participations since 2015. They have been using the Global-PPS data to create a hospital stewardship program and in August 2018, the Nigerian working group on AMS was established.

Launched almost one year ago, the drive-AMS project is gaining significant traction. The project aims to implement antimicrobial stewardship (AMS) programmes in healthcare facilities as an important contribution to the fight against antibiotic resistance.

In June 2024, the Institute of Tropical Medicine in Antwerp will be organizing a practical 3-week training on antibiotic resistance and its containment at hospital level in low-resource settings.

Global-PPS is again joining the World Antibiotic Awareness Week, a global campaign improving awareness and understanding of antimicrobial resistance (AMR) and encouraging best practices. This year’s theme is again ‘Preventing antimicrobial resistance together’. It focuses on a One Health approach and inspires collaboration across sectors. AMR is a threat to humans, animals, plants and the environment and fighting it is a global endeavour.

Read our interview with Dr. Noritaka Sekiya, a physician for infectious diseases at the Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital in Japan. He’s working as a consultant in infectious diseases and infection prevention & control. Dr. Sekiya’s other expertise is field epidemiology. In this interview, he addresses the AMR situation in Japan and how using Global-PPS has been a part of tackling this problem.

The Global-PPS tool is continuously improved and expanded. Our newest addition is the interactive reporting dashboard, now available on the online Global-PPS data entry environment. This new feature is meant to replace the longitudinal feedback reports in the pdf-format, and will enable hospitals to customise their analyses.

Read our interview with Professor Gordana Mijovic and Doctor Ivana Djuković, expert members from the Montenegrin Global-PPS network. In this testimonial, they elaborate on the challenges and barriers in the fight against antimicrobial resistance (AMR), the advantages of collaborating with Global-PPS, and the future perspectives of AMR reduction in Montenegro .

Global-PPS is launching a new addition to its web-based tool, namely the outpatient module. This new feature was developed following requests of several Global-PPS participants, as patient-level data from the outpatient setting are generally limited.

This past week, the 33rd European Congress of Clinical Microbiology & Infectious Diseases, ECCMID, took place in Copenhagen, Denmark. Just as last year, Global-PPS was there to present their findings.

Our Selection of Publications has been updated for 2023. The document presents the Global Point Prevalence Survey, its methodology and facilitating features.

Last week, drive-AMS organised a Training of Trainers Course in Nijmegen, hosted by Radboudumc. The course combined their Dutch AMS Masterclass and the Global-PPS tool and expertise. It was the perfect opportunity to connect, collaborate and exchange ideas!

To strengthen the worldwide response to IFDs and antifungal resistance, the World Health Organisation (WHO) has developed a Fungal Priority Pathogens List (FPPL). Its aim is to focus and drive further research and policy interventions. This list was inspired by the Bacterial Priority Pathogens List that WHO published in 2017.

On 9 December 2022, the World Health Organisation (WHO) published the WHO AWaRe (Access, Watch, Reserve) Antibiotic Book. It is a concise, evidence-based guide for choosing antibiotics, doses, routes of administration and duration of treatment for more than 30 of the most common clinical infections in children and adults, in both primary health care and hospital settings.

On the 1st of November 2022, Radboud University Medical Centre (Radboudumc) and University of Antwerp joined forces to launch drive-AMS, a new project funded under the EU4Health Programme. This project aims to intensify antimicrobial stewardship (AMS) programmes across the European Union by improving prudent antimicrobial use (AMU) and strengthening AMU surveillance, which are both key priorities of the EU One Health Action Plan on AMR.

Every year from 18 until 24 November the World of Antimicrobial Awareness Week (WAAW) takes place. It is a global campaign to improve awareness and understanding of antimicrobial resistance (AMR) and encourages best practices among the public, One Health stakeholders, and policymakers. They all play a critical role in reducing the further emergence and spread of AMR.

The Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) has published a paper describing the development and implementation of an Antimicrobial Stewardship (AMS) checklist for Sub-Saharan Africa.

Doctor Anthony Enimil is a Paediatric Infectious Disease Specialist, based in the Komfo Anokye Teaching Hospital in Ghana. He is also a member of the Hospital Antimicrobial Stewardship Committee. In this interview, Anthony shares his experience with Global-PPS, the advantages of the study and some future challenges.

Doctors Without Borders will soon deploy its innovative Antibiogo application in several of its laboratories in Mali, Jordan, Yemen and the Central African Republic. This free, open source and offline downloadable Android application will contribute to an increase of information technology to support antimicrobial prescribing in low-and middle-income countries (LMIC).

We interviewed Mari Rose De los Reyes, an infectious disease specialist at the Research Institute for Tropical Medicine (RITM) in Manila, the Philippines. Mari Rose coordinates the national Global-PPS in the country. This network has grown from 16 initial sites to 80 sites all over the Philippines.

Read our unique testimonial with Kate Clezy and Marije Baan from Doctors Without Borders (MSF) about their involvement in Global-PPS.

In May 2022, the Russian network of hospitals within the Global-PPS project published a new paper in the Tropical Medicine and Infectious Disease journal. The goal of the study was to evaluate prescribing patterns of antimicrobials in COVID-19 patients in several Russian multi-field hospitals, and to quantify the prescribing in relation to quality indicators.

At the 32st edition of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), the Global-PPS team from the University of Antwerp and participants from Georgia, Montenegro, and the Philippines present their latest Global-PPS results. This year, ECCMID will take place for the first time as a hybrid event both online and on-site in Lisbon, Portugal on 23 – 26 April 2022.

On December 21, 2021, a network of Canadian hospitals published a paper in CMAJ Open, reporting on their Global-PPS results. This study describes antimicrobial use (AMU) based on detailed patient-level data in Canadian hospitals in 2018 in terms of antimicrobial prevalence, indications and agent selection in adult and paediatric medical, surgical and intensive care wards.

Africa CDC (Africa Centres for Disease Control and Prevention) and CDDEP (Center for Disease Dynamics, Economics & Policy) published the first edition of the African antibiotic treatment guidelines for common bacterial infections and syndromes.

The Global-PPS in Iran primarily started in 2015 in the Kurdistan University of Medical Sciences, concurrently with the first global attempt for data collection about antibiotic consumption conducted by the University of Antwerp, Belgium. From 2017, the Global-PPS was repeated every year with additionaldata collected in 4 new hospitals in Sanandaj.

For a long time, the overuse and inappropriate use of both antibiotics and antimalarial drugs has been observed. This poses a threat to the financial situation of this rural hospital. The problem is known, but behavioral change is challenging.

Optimizing antimicrobial prescribing in hospitals through antimicrobial stewardship (AMS) is essential in addressing the threat of antimicrobial resistance. This study reports the results of five consecutive PPS in a private tertiary hospital in the Philippines, using the Global-PPS protocol.

The 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), will take place in Vienna, Austria from 9 – 12 July 2021. Abstracts can be submitted from 11 January to 24 February 2021.

Global-PPSチームは、Global Point Prevalence Survey of Antimicrobial Consumption and Resistance（Global-PPS）ネットワークの病院における抗菌薬スチュワードシップの実施に焦点を当てた論文を発表した。.

Over the past few months, the Global-PPS team has been busy updating the real-time feedback report. They now also provide insight into prevalence’s for the different antibiotic subgroups, healthcare-associated infections and use of invasive devices and the novel WHO AWaRE classification.

When participating in the Global-PPS, online data entry is an important step. We have now created a set of tutorial videos to guide you through the process of online data entry, validation and reporting.

At the 31st edition of ECCMID, Global-PPS participants from Nigeria, Belgium, the Philippines, Cote d’Ivoire, and Iran will present seven abstracts making use of the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance.

On 5 April 2021, the Global-PPS team published a paper in the Journal of Antimicrobial Chemotherapy that focuses on hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe).

The 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), will take place in Vienna, Austria from 9 – 12 July 2021. Abstracts can be submitted from 11 January to 24 February 2021.

トビリシ国立医科大学の小児科医で講師のイルマ・コリンテリ博士は、2015年の当初からGlobal-PPSプロジェクトに参加している。今年初め、彼女はグルジアの病院における抗生物質の使用に関する博士論文の提出に成功した。以下、彼女の証言をお読みください！

2021年には、Global-PPSの手法を紹介し、プロトコルとデータ入力アプリケーションのアップデートについて議論する一連のウェビナーを開始する予定である。.

Global-PPSプロトコルはCOVID-19患者の調査に適応されている。ウェブサイトはフランス語、日本語、ロシア語、スペイン語に翻訳されている。さらに多くの言語に対応する予定である。Global-PPSがどのように国レベルで展開され、これらのデータがどのように博士課程に利用できるかについての2つの素晴らしいストーリーをお読みください。.

イランにおけるGlobal-PPSは主に、ベルギーのアントワープ大学が実施した抗生物質消費に関するデータ収集の世界的な最初の試みと同時に、2015年にイランの2つの大都市、すなわちシラーズとクルディスタン医科大学で開始された。.